Submission Details
| 510(k) Number | K240253 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 30, 2024 |
| Decision Date | March 21, 2024 |
| Days to Decision | 51 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
K240253 is an FDA 510(k) clearance for the Reach Needle, a Needle, Conduction, Anesthetic (w/wo Introducer) (Class II — Special Controls, product code BSP), submitted by Aerin Medical, Inc. (Mountain View,, US). The FDA issued a Cleared decision on March 21, 2024, 51 days after receiving the submission on January 30, 2024. This device falls under the Anesthesiology review panel. Regulated under 21 CFR 868.5150.
| 510(k) Number | K240253 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 30, 2024 |
| Decision Date | March 21, 2024 |
| Days to Decision | 51 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
| Product Code | BSP — Needle, Conduction, Anesthetic (w/wo Introducer) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 868.5150 |